EquityFolio

JNJ

NYSE Healthcare

Johnson & Johnson

$255.56

-$9.97 (-3.75%)

Live quote

52w: $164.23 – $274.90

Loading chart…
P/E Ratio18.82
P/B Ratio6.18
EV/EBITDA12.97
Debt/Equity0.59
ROE32.87%
ROIC13.71%
Revenue Growth0.00%
Gross Margin72.78%
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Own JNJ? Track it here.

Create a free account to add JNJ to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account